OREM, UTAH—Aribex, a leader in handheld X-ray technologies, has announced that the Aribex NOMAD Pro handheld X-ray system has been selected as a finalist in the 2012 Medical Design Excellence Awards competition.
Unlike some of the bulky wall-mount and portable X-ray systems in use, the NOMAD Pro is lightweight, rechargeable, and portable. The NOMAD Pro, invented by Dr. D. Clark Turner, CEO of Aribex, is becoming an X-ray device of choice for dental professionals.
“I’d like to say that the reception and recognition of the NOMAD Pro has far exceeded our expectations, but that wouldn’t be true,” said Turner. “We always believed our device would have a significant impact on the way X-rays are taken. This award underpins the satisfaction that comes from knowing we are making a difference in the health of people who otherwise would not have access to care.”
Related information, click here.
The MDEA is one of the medical device industry’s premier design awards competitions, and recognizes contributions and advances in the design of medical products. The winners will be announced May 23, 2012, during a cocktail reception at the Marriott Hotel in downtown Philadelphia, Pa.
“This Medical Design Excellence Award is one more validation of the safety, value, and effectiveness of our NOMAD handheld X-ray systems,” said Ken Kaufman, president and CFO of Aribex.
“Millions around the world have been safely diagnosed with the assistance of our products, but we regret that a small handful of states continue to hinder the NOMAD from improving access to care for their respective populations. We call on the reluctant regulators in Kentucky, New Hampshire, Maryland, Michigan, and Minnesota to stop denying access to care for thousands of their residents by granting general handheld use approval of the NOMAD. Practitioners in these states can go to www.aribex.com/get-nomad-approved/ to express their desire to have NOMAD handheld X-ray system approved in their areas.
“It is inconsistent that children in places like Guatemala, Bolivia, Haiti, El Salvador, or Sierra Leone can be treated with state-of-the-art technology that is not available in these restrictive states,” Kaufman added.
For more information, visit www.aribex.com.
To comment on this subject, go to community.pennwelldentalgroup.com/.
